TriSalus Life Sciences, Inc. (TLSIW) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $20.44M | +139.8% |
| 2024 | $8.53M | -27.6% |
| 2023 | $11.78M | +25.1% |
| 2022 | $9.41M | +4586.3% |
| 2021 | $200.9K | -85.0% |
| 2020 | $1.33M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $20.44M | +139.8% |
| 2024 | $8.53M | -27.6% |
| 2023 | $11.78M | +25.1% |
| 2022 | $9.41M | +4586.3% |
| 2021 | $200.9K | -85.0% |
| 2020 | $1.33M | — |